Nihon Kohden (PK) Quote - NHNKY | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Nihon Kohden (PK) (NHNKY) Share Price

Nihon Kohden (PK) (NHNKY)

15.96

-0.039

( -0.24% )

Updated: 11:41:25

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

15.96

Bid

12.17

Ask

16.00

Volume

328

15.96 Day's Range 15.96

10.0601 52 Week Range 20.00

Market Cap

Previous Close

15.999

Open

15.96

Last Trade

Last Trade Time

11:05:50

Financial Volume

US$ 5,235

VWAP

15.96

Average Volume (3m)

6,802

Shares Outstanding

168,252,816

Dividend Yield

1.52%

PE Ratio

0.15

Earnings Per Share (EPS)

101.19

Revenue

221.99B

Net Profit

17.03B

Sector

Ortho,prosth,surg Appl,suply

Industry

Hospital Supply/management

Website

www.nihonkohden.co.jp

Headquarters

Shinjuku, Tokyo, Jpn

Founded

1984

Nihon Kohden (PK) is listed in the Ortho,prosth,surg Appl,suply sector of the OTCMarkets with ticker NHNKY. The last closing price for Nihon Kohden (PK) was US$16. Over the last year, Nihon Kohden (PK) shares have traded in a share price range of US$ 10.0601 to US$ 20.00.

Nihon Kohden (PK) currently has 168,252,816 shares outstanding. The market capitalization of Nihon Kohden (PK) is US$2.69 billion. Nihon Kohden (PK) has a price to earnings ratio (PE ratio) of 0.15.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.9299	32.6672263738	12.0301	16.419	12.0301	2306	14.92582401	DR
4	1.91	13.5943060498	14.05	17.11	12.0301	14371	14.17688874	DR
12	-4.039	-20.1960098005	19.999	20	10.49	6802	14.01485605	DR
26	2.43	17.9600886918	13.53	20	10.0601	4639	13.94585635	DR
52	3.665	29.8088653924	12.295	20	10.0601	4743	13.57367557	DR
156	-1.49	-8.53868194842	17.45	20	9.95	4899	12.69451138	DR
260	1.35	9.24024640657	14.61	21.05	9.95	3928	13.27979081	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EHVVFEhave Inc (CE)	US$ 0.0006 (59,900.00%)	15.71k
NTRRNeutra Corporation (CE)	US$ 0.0002 (19,900.00%)	4.62M
RENORenovare Environmental Inc (CE)	US$ 0.0001 (9,900.00%)	35.75k
MNGGMining Global Inc (PK)	US$ 0.0001 (9,900.00%)	975k
CGSICGS International Inc (CE)	US$ 0.0001 (9,900.00%)	150
JXMNFJaxon Mng Inc (PK)	US$ 0.000001 (-99.99%)	80k
FTCHQFarfetch Limited (CE)	US$ 0.000001 (-99.50%)	179.08k
SUNWQSunworks Inc (CE)	US$ 0.000001 (-99.50%)	626.81k
ONPHOncology Pharma Inc (CE)	US$ 0.000001 (-99.50%)	5.1k
BLSPBlue Sphere Corporation (CE)	US$ 0.000001 (-99.50%)	253.55k
AURIAuri Inc New (PK)	US$ 0.0001 (0.00%)	556.32M
SPQSSportsQuest Inc (PK)	US$ 0.0004 (0.00%)	366.04M
DRNKNoHo Inc (PK)	US$ 0.0002 (-33.33%)	318.24M
HMBLHUMBL Inc (PK)	US$ 0.0003 (0.00%)	191.03M
AAPJAAP Inc (PK)	US$ 0.0004 (100.00%)	185.42M

236T568

236T568 4 minutes ago

Update on the Jack Smith DC Jan 6th Case

https://x.com/MuellerSheWrote/status/1839708161697296466

Monksdream

Monksdream 4 minutes ago

LI a Chinese ev stock
https://investorshub.advfn.com/uimage/uploads/2024/9/27/ilhjiIMG_2189.gif

zatafour

zatafour 5 minutes ago

PokerStar

PokerStar 5 minutes ago

And there it is....GREEN! Now to work on new higher highs...

PokerStar

louieforpar

louieforpar 5 minutes ago

The rapid development of COVID-19 vaccines in under a year has raised concerns, which can lead to vaccine hesitancy. But AMA member Peter Hotez, MD, PhD, reassures that while the COVID-19 pandemic has spurred global cooperation for vaccine research and distribution, it has been a decade in the makin

seven77

seven77 6 minutes ago

911 trade just went in . I think they’re gonna let rip…

vlispxpert

vlispxpert 6 minutes ago

YINN next week puts load

jour_trader

jour_trader 6 minutes ago

I can’t imagine that deal going through. It just pushes more litigation and accountability for the owners’ wrongdoing.

Also a sad side note is some of the money that states have received from these opioid lawsuits is going towards other things, which I personally think is wrong. If t

Surfacetite

Surfacetite 6 minutes ago

Seems can’t hold. What to do.

Monksdream

Monksdream 6 minutes ago

XPEV Chinese ev stock
https://investorshub.advfn.com/uimage/uploads/2024/9/27/xgrtsIMG_2188.gif

tjvs

tjvs 7 minutes ago

With all the stuff I have read I'm waiting for a major lawsuit against U V. That's my opinion.

RIGATONI

RIGATONI 7 minutes ago

A little action I have a small block...

RHCO .033 Take time to review, still with a smaller float..

Venture Capital | Readen Holding Corporation RHCO

https://www.readenholdingcorp.com/

I-Glow

I-Glow 7 minutes ago

Smith is clueless about securities law.

You posted:

"The other issue I foresee with extending the warrants is this: FORW S-1 is being reviewed right now for SEC approval. They've already made a few amendments. If they extend the warrants, doesn't that mean they need to

Ronin

Ronin 7 minutes ago

Nothing but “Word salad” from CEO…

“Our journey has taught us that our true strengths lie in identifying and nurturing successful mobile games found globally rather than developing them from the ground up. ..”

Why would you have to “nurture” a game that is already succe

Ronin

Ronin 7 minutes ago

Nothing but “Word salad” from CEO…

“Our journey has taught us that our true strengths lie in identifying and nurturing successful mobile games found globally rather than developing them from the ground up. ..”

Why would you have to “nurture” a game that is already succe

PonkenPlonken

PonkenPlonken 7 minutes ago

APLD 8.76 remember this is the company that NVDA wanted to be a part of

Zorax

Zorax 7 minutes ago

I have never seen such a blatant scam with so many people willing to throw money at it.

I have for sure.. there's this other one owned by a criminal and he and his criminal cohorts with the help of a bunch of foreign oligarchs who set up a phony merger while giving themselves 100's o

floblu14

floblu14 8 minutes ago

Baird Reiterates Outperform Rating on Enanta Pharmaceuticals (ENTA)

September 27, 2024 6:56 AM EDT
Baird analyst Brian Skorney reiterated an Outperform rating and $26.00 price target on Enanta Pharmaceuticals (NASDAQ: ENTA).The analyst commented: "Incrementally ... [needs

pennylandspirit

pennylandspirit 8 minutes ago

IS THIS STOCK DEAD NOW?

Tradesmart7

Tradesmart7 8 minutes ago

https://x.com/PikachOTC/status/1839680050674716899

Brock993

Brock993 8 minutes ago

https://x.com/ProtextP/status/1839700080875417832

louieforpar

louieforpar 8 minutes ago

That’s a big misconception. That vaccine was in the works for years.

“It was all developed while he was still President”

QuicKtip

QuicKtip 8 minutes ago

$XXII 22nd Century owns a number of brands which among others include Pinnacle, Moonlight, Magic and Ranger, in addition to its VLN® 95% reduced nicotine content branded cigarettes, the only combustible cigarette authorized by the U.S. Food and Drug Administration specifically designed to reduce smo

QuicKtip

QuicKtip 8 minutes ago

$XXII 22nd Century owns a number of brands which among others include Pinnacle, Moonlight, Magic and Ranger, in addition to its VLN® 95% reduced nicotine content branded cigarettes, the only combustible cigarette authorized by the U.S. Food and Drug Administration specifically designed to reduce smo

Nihon Kohden (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions